Stocks & Investing
Fri, August 2, 2024
[ 12:00 AM ] - WOPRAI
Mon, June 24, 2024
[ 12:00 AM ] - WOPRAI
Mon, June 17, 2024
[ 12:00 AM ] - WOPRAI
Tue, March 26, 2024
[ 12:00 AM ] - WOPRAI
Fri, January 26, 2024
[ 12:00 AM ] - WOPRAI
Thu, January 18, 2024
[ 12:00 AM ] - WOPRAI
Thu, December 21, 2023
[ 12:00 AM ] - WOPRAI
Fri, October 13, 2023
[ 12:00 AM ] - WOPRAI
Thu, August 31, 2023
[ 12:00 AM ] - WOPRAI
Mon, July 24, 2023
[ 12:00 AM ] - WOPRAI
Mon, April 3, 2023
[ 12:00 AM ] - WOPRAI
Thu, February 23, 2023
[ 12:00 AM ] - WOPRAI
Fri, August 26, 2022
[ 12:00 AM ] - WOPRAI
Mon, July 25, 2022
[ 12:00 AM ] - WOPRAI
Fri, May 27, 2022 Allison Bratzel Maintained (TVTX) at Hold with Increased Target to $12 on, Aug 2nd, 2024
Allison Bratzel of Piper Sandler, Maintained "Travere Therapeutics, Inc." (TVTX) at Hold with Increased Target from $11 to $12 on, Aug 2nd, 2024.
Allison has made no other calls on TVTX in the last 4 months.
There are 2 other peers that have a rating on TVTX. Out of the 2 peers that are also analyzing TVTX, 0 agree with Allison's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Allison
- Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $19 on, Tuesday, May 7th, 2024
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $18 on, Tuesday, May 7th, 2024
